All data are based on the daily closing price as of October 20, 2026
y
Yuhan
000100.KO
64.94 USD
-0.79
-1.20%
Overview
Last close
64.94 usd
Market cap
4.78B usd
52 week high
97.67 usd
52 week low
43.25 usd
Target price
84.42 usd
Valuation
P/E
27.9136
Forward P/E
14.881
Price/Sales
2.8237
Price/Book Value
2.3218
Enterprise Value
4.09B usd
EV/Revenue
2.3802
EV/EBITDA
14.8188
Key financials
Revenue TTM
1.72B usd
Gross Profit TTM
571.12M usd
EBITDA TTM
152.57M usd
Earnings per Share
2.36 usd
Dividend
0.45 usd
Total assets
2.15B usd
Net debt
N/A usd
About
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.